| ||
Merck: Vytorin helps kidney-disease patients MarketWatch By MarketWatch TEL AVIV (MarketWatch) – Merck & Co. said its Vytorin cholesterol-lowering drug was shown in a study of kidney-disease patients to reduce the incidence of first major heart attacks and strokes by a "highly statistically significant" ... See all stories on this topic » | ||
| ||
UN urges tobacco additive limits BBC News A conference on tobacco held in Uruguay has recommended that additives used to make cigarettes more appealing to new smokers should be restricted or banned. Delegates from over 170 countries that have signed a UN tobacco control treaty also said ... See all stories on this topic » | ||
Teen tobacco use falls, but pressure to buy remains Minneapolis Star Tribune As east metro students say no more often, the industry counters with marketing, an official says. By KEVIN GILES, Star Tribune Washington County's proposed ordinance change will go to a public hearing on Dec. 21 at 9 am in the fifth-floor board room of ... See all stories on this topic » | ||
Consumer Risks Feared as Health Law Spurs Mergers New York Times By ROBERT PEAR WASHINGTON — When Congress passed the health care law, it envisioned doctors and hospitals joining forces, coordinating care and holding down costs, with the prospect of earning government bonuses for controlling costs. ... See all stories on this topic » | ||
Four Loko and Other Malt Alcoholic Drinks to be Pulled From Shelves KBTX Have you gotten "Loko" yet? The slang being used among drinkers of malt alcoholic beverages like Four Loko because of its effect on some people. "I will probably try to buy as many as I can get before they are out and try to hold on to them. ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment